Diphenytoin, Riluzole and Lidocaine: Three Sodium Channel Blockers, With Different Mechanisms of Action, Decrease Hippocampal Epileptiform Activity

Neuropharmacology - United Kingdom
doi 10.1016/j.neuropharm.2013.04.057
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neonatal Episodic Laryngospasm Treated With Sodium Channel Blockers

Pediatric Neurology Briefs
2010English

Electrophysiological Mechanisms of Kainic Acid-Induced Epileptiform Activity in the Rat Hippocampal Slice

Journal of Neuroscience
Neuroscience
1984English

Dynamics of Epileptiform Activity in Mouse Hippocampal Slices

Journal of Biological Physics
Cell BiologyMolecular BiologyMolecular Physics,BiophysicsAtomicOptics
2011English

Precision Medicine: SCN8A Encephalopathy Treated With Sodium Channel Blockers

Neurotherapeutics
NeurologyPharmacology
2015English

Marked QRS Complex Abnormalities and Sodium Channel Blockade by Propoxyphene Reversed With Lidocaine.

Journal of Clinical Investigation
Medicine
1989English

Comparison of Patient Characteristics and Health Care Utilization in Epilepsy Patients Adding Adjunctive Lacosamide to Sodium Channel Blockers Versus Non-Sodium Channel Blockers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Interactions Between Quaternary Lidocaine, the Sodium Channel Gates, and Tetrodotoxin

Biophysical Journal
Biophysics
1979English

Pyrroline Derivatives of Mexiletine-Like Compounds Have Dual Activity as Use-Dependent Sodium Channel Blockers and Antioxidant

Biophysical Journal
Biophysics
2018English

Switching From Traditional Sodium Channel Blockers to Lacosamide in Patients With Epilepsy

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy